Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 6, 2009

View Archived Issues

New Aurora B kinase inhibitors reported in recent Boehringer Ingelheim patent

New mGluR1 and mGluR5 receptor ligands discovered at Gedeon Richter

AstraZeneca identifies novel CRTh2 receptor ligands for respiratory disorders

Novel selective AT2 receptor agonists disclosed by Mitsubishi Tanabe

NVP-BEZ-235 a candidate for ovarian cancer treatment

Novel PDF inhibitors prepared and tested at Il-Dong

Novartis presents fourth quarter highlights

Phase II results for temozolomide in non-small cell lung cancer reported

Toxicity seen with everolimus/tacrolimus regimen in stem cell transplant patients

Prolonged dosing of TLR-7 agonist 852A assessed in cancer patients

Transition Therapeutics completes patient enrollment of phase II TT-223 study

Cytopia successfully concludes phase I oral CYT-997 trial

Raptor completes enrollment in phase IIa nonalcoholic steatohepatitis trial

Adventrx completes enrollment in ANX-514 bioequivalence study

BioDelivery Sciences presents initial phase I Bioral amphotericin B results

King offers new dosage strengths of Avinza for chronic pain

Trial aimed at regenerating insulin-producing capacity gets FDA approval

Oncolys initiates French phase Ib clinical study of Festinavir in HIV patients

Favrille changes name to MMR Information Systems

Oncolytics and the CTRC at UTHSCSA enter collaboration for phase II studies of Reolysin

GlaxoSmithKline and Genmab seek E.U. marketing authorization for Arzerra

Dyax expands antibody discovery collaboration with Biogen

Immunomedics' hPAM4 labeled with yttrium-90 receives fast track designation

Partnership aims to develop proof-of-concept vaccine against Chikungunya virus

UCB meets with FDA to define Cimzia regulatory path in rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...